Harrysson S, Eloranta S, Ekberg S, Enblad G, et al. Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients. Br J Haematol 2022 Apr 25. doi: 10.1111/bjh.18197.
PMID: 35468219